Canada
7 Vaccines Approved for Use in Canada
Protein Subunit
Novavax
Nuvaxovid
Approved in 37 countries
16 trials in 12 countries
Approval Source: covid-vaccine.canada.ca
VLP
RNA
RNA
Pfizer/BioNTech
Comirnaty
Approved in 146 countries
84 trials in 27 countries
Approval Source: canada.ca
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Approval Source: canada.ca
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 140 countries
64 trials in 31 countries
Approval Source: covid-vaccine.canada.ca
Non Replicating Viral Vector
Serum Institute of India
Covishield (Oxford/ AstraZeneca formulation)
Approved in 49 countries
4 trials in 1 country
Approval Source: theglobeandmail.com
12 in Clinical Trials in Canada
Protein Subunit
Novavax
Nuvaxovid
Approved in 37 countries
16 trials in 12 countries
VLP
Medicago
Covifenz
Approved in 1 country
6 trials in 6 countries
RNA
Moderna
Spikevax
Approved in 86 countries
67 trials in 23 countries
RNA
Pfizer/BioNTech
Comirnaty
Approved in 146 countries
84 trials in 27 countries
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 140 countries
64 trials in 31 countries
Protein Subunit
University of Saskatchewan
COVAC-2
5 trials in 1 country
VLP
VBI Vaccines Inc
VBI-2902a
2 trials in 1 country
DNA
Entos Pharmaceuticals Inc
Covigenix VAX-001
2 trials in 1 country
RNA
Providence Therapeutics Holdings Inc.
PTX-COVID19-B
2 trials in 2 countries
Protein Subunit
University of Saskatchewan
COVAC-1
Non Replicating Viral Vector
McMaster University
Ad5-triCoV/Mac
Non Replicating Viral Vector
McMaster University